Healthcare -
Biotechnology - NASDAQ - US
$ 44.405
-3.47 %
$ 5.26 B
Market Cap
-8.44
P/E
Price Target
Average
108.31%
Revenue Forecast
Estimate
427.20%
EBIT
Estimate
--30.52%
Net Income
Estimate
30.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytokinetics, Incorporated
Wall Street analysts predict an average 1-year price target for CYTK of $92.5 , with forecasts ranging from
a
low of
$60 to a high of $120 .
CYTK Lowest Price Target
Wall Street Target
60 USD
35.12%
CYTK Average Price Target
Wall Street Target
92.5 USD
108.31%
CYTK Highest Price Target
Wall Street Target
120 USD
170.24%
REVENUE FORECAST
Revenue Forecast Chart CYTK
EBIT FORECAST
EBIT Forecast Chart CYTK
NET INCOME FORECAST
Net Income Chart CYTK